RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY

被引:0
作者
Goy, A. [1 ]
Offner, F. [2 ]
Martinelli, G. [3 ]
Caballero, D. [4 ]
Gadeberg, O. [5 ]
Gaidano, G. [6 ]
Press, O. [7 ]
Fine, G. [8 ]
Chai, A. [8 ]
Sahin, D. [9 ]
Sehn, L. [10 ]
机构
[1] John Theurer Canc Ctr, Hackensack, NJ USA
[2] Univ Ghent, Ghent, Belgium
[3] Univ Bologna, S Orsola Malpighi Hosp, Bologna, Italy
[4] Hosp Clin Univ, Salamanca, Spain
[5] Vejle Hosp, Vejle, Denmark
[6] Amedeo Avogadro Univ Eastern Piedmont, Novara, Italy
[7] Univ Washington, Seattle, WA 98195 USA
[8] Genentech BioOncol, San Francisco, CA USA
[9] Kocaeli Univ, Kocaeli, Turkey
[10] BC Canc Agcy, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0790
引用
收藏
页码:322 / 323
页数:2
相关论文
empty
未找到相关数据